Caladrius Biosciences
Why Robinhood?
You can watch CLBS and buy or sell other stocks, ETFs, and their options commission-free!About CLBS
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors.
CLBS Key Statistics
Stock Snapshot
Caladrius Biosciences(CLBS) stock is priced at $2.66, giving the company a market capitalization of 24.26M. It carries a P/E multiple of -0.65.
On 2026-11-04, Caladrius Biosciences(CLBS) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Caladrius Biosciences(CLBS) stock has reached 0, versus its average volume of 47.86K.
The stock's 52-week range extends from a low of $0.96 to a high of $5.07.
The stock's 52-week range extends from a low of $0.96 to a high of $5.07.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.